Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Acg Pam Pharma Technologies Pvt Ltd. is managing a patent portfolio in the Medical Devices & Mechanical Engineering technology area. The company currently faces 1 pending office action, which is the only active matter reported in the data. This prosecution is confined to 1 distinct art unit, suggesting a specialized mechanical or medical application is under review. Practitioners should note that this streamlined engagement allows for a concentrated effort on the lone pending matter.
The single pending office action is assigned to examiner GERTH, KATIE L, who serves as the busiest examiner for the portfolio with 1 pending office action. With 1 distinct examiner involved, the company's immediate prosecution strategy is focused on a single point of contact at the USPTO. This arrangement in the Medical Devices & Mechanical Engineering sector facilitates a direct and focused negotiation process. Because the workload is limited to 1 distinct examiner, the company can tailor its approach to this specific individual's examination style. The 1 distinct art unit reflects the specific technical niche of the current filing.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GERTH, KATIE L | 1 | 75.8% | +16.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18277990 | METHOD AND APPARATUS FOR OBJECT CLOSING | GERTH, KATIE L | 3d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18277990 | METHOD AND APPARATUS FOR OBJECT CLOSING | GERTH, KATIE L | 3d overdue |
| Art Unit | Apps |
|---|---|
| 3731 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18277990 | METHOD AND APPARATUS FOR OBJECT CLOSING | GERTH, KATIE L | 3731 | §102§103§112 | Final Rejection | 3d overdue | Pending | Aug 20, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAcg Pam Pharma Technologies Pvt Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Katie L Gerth has the most, with 1 of Acg Pam Pharma Technologies Pvt Ltd.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
